PLSE NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Pulse Biosciences Inc · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 35.13 USD
16.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 54.8% above the Trend Line and sits at 93.2% of its 52-week range. The latest completed week returned 16.2%, after a 20.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. Options positioning is volatility with 57/100 conviction, while the latest news-sentiment score is 58/100. Near-term considerations: price is close to its 52-week high; earnings are due in 5d.

Setup score 71 out of 100
Latest Close 35.13 USD 31 Jul 2026
1W Return 16.2% latest completed week
4W Return 20.3% short-term follow-through
12W Return 84.1% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
What is working
  • The trend backdrop is active with a 25-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 4 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 16.2% Latest completed week; four-week move 20.3%. Indicator stack 76/84 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 57/100 conviction; expected move 15.8%. News sentiment 58/100 49 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 54.8% above the Trend Line and sits at 93.2% of its 52-week range. The latest completed week returned 16.2%, after a 20.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7912-week average 0.71

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.79Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers

No recent accumulation markers. 4 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 20.3% over four weeks, 84.1% over 12 weeks, and 138.2% over one year. The current trend has remained active for 25 consecutive weeks.

Performance by holding period

1W16.2%
4W20.3%
12W84.1%
26W154.0%
52W138.2%
Active trend streak25 weeks
Active weeks in one year29
Trend breadth55.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.57Latest activity-pressure read.
Pressure change67.0%Four-week change in activity pressure.
Leadership64.86Latest relative-leadership reading.
RS change71.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength12/100Blend of value, momentum, and quality. Underlying universe rank 89; rank 1 is best.
Value11/100Relative valuation strength. Underlying universe rank 90; rank 1 is best.
Quality2/100Profitability and accounting quality. Underlying universe rank 99; rank 1 is best.
Momentum94/100Medium-term price momentum. Underlying universe rank 7; rank 1 is best.
Growth11/100Revenue and earnings growth. Underlying universe rank 90; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
2785.9x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-2.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-91.1%
Gross profit retained from each unit of revenue.
Operating margin
-10004.8%
Operating profit retained from revenue.
Free-cash-flow margin
-7309.3%
Free cash flow generated from revenue.
Return on invested capital
-1097.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-69.9%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

PLSE shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 0.00, expected move of 15.8%, and Sharemaestro trend signal active.

Conviction57/100
Expected move15.8%
Put/call volume0.00
Pressure100
Speculation1
Volatility96
Trend agreement20
Open options detail
Insider activity11 / 0

11 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment58/100

Weighted news tone is neutral across 49 relevant articles.

17 positive · 31 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move15.8%Nearest-chain priced movement where available.
52-week drawdown-4.5%Distance below the 52-week high.
13-week volatility10.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+50.0%Week of 6 Feb.
Worst week-18.8%Week of 10 Apr.
Latest week+16.2%Week of 31 Jul.

Shape of recent returns

Strong gains12
Modest gains3
Flat weeks0
Modest losses4
Sharp losses7
Recent vol10.0%13-week weekly-return volatility.
Base vol11.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew11.0% / -6.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape68/100

Trend, activity pressure, participation, and risk combine to a 68/100 tape read.

 Indicator analysis80/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.79; 4 reversal markers Factors26/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 59; Small Cap Core rank 90 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options42/100

PLSE shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 0.00, expected move of 15.8%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 15.8% Sentiment58/100

Weighted news tone is neutral across 49 relevant articles.

Pulse Biosciences’ Aug. 11 Boston fireside chat will be webcast Insiders11 / 0

11 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings5d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202635.13 USD16.2%22.69 USD15.34 USD1.5764.862.6MOn
24 Jul 202630.23 USD5.4%21.96 USD15.16 USD1.3544.832.0MOn
17 Jul 202628.68 USD9.1%21.44 USD15.02 USD1.2536.741.1MOn
10 Jul 202626.29 USD-10.0%20.99 USD14.88 USD0.9821.231.5MOn
3 Jul 202629.20 USD2.7%20.59 USD14.76 USD0.9437.751.2MOn
26 Jun 202628.45 USD11.1%20.06 USD14.61 USD0.8236.522.8MOn
19 Jun 202625.60 USD5.0%19.56 USD14.48 USD0.5718.301.2MOn
12 Jun 202624.37 USD-3.8%19.14 USD14.35 USD0.6316.041.6MOn
5 Jun 202625.33 USD1.3%18.81 USD14.24 USD0.6823.701.7MOn
29 May 202625.00 USD-3.4%18.48 USD14.12 USD0.4016.861.0MOn
22 May 202625.89 USD5.5%18.21 USD14.00 USD0.3424.561.7MOn
15 May 202624.55 USD28.7%17.95 USD13.87 USD0.3419.773.6MOn
8 May 202619.08 USD-8.4%17.72 USD13.76 USD0.34-7.121.3MOn
1 May 202620.83 USD-9.5%17.67 USD13.69 USD0.496.391.2MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.